<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col width="38.1%"></col>
<col width="26.6%"></col>
<col width="35.3%"></col>
<tbody>
<tr>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     "> Concomitant Drug</td>
<td align="center" stylecode="     Botrule          Rrule     "> Effect on Concentration of Lamotrigine or Concomitant Drug</td>
<td align="center" stylecode="     Botrule          Rrule     "> Clinical Comment</td>
</tr>
<tr>
<td rowspan="2" stylecode="     Botrule         Lrule          Rrule     " valign="top"> Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel</td>
<td stylecode="     Rrule     " valign="top"> <paragraph>↓ Lamotrigine </paragraph>
</td>
<td stylecode="     Rrule     " valign="top"> Decreased Lamotrigine levels approximately 50%. </td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> ↓ levonorgestrel</td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decrease in levonorgestrel component by 19%.</td>
</tr>
<tr>
<td rowspan="2" stylecode="     Botrule         Lrule          Rrule     " valign="top"> Carbamazepine (CBZ) and CBZ epoxide</td>
<td stylecode="     Rrule     " valign="top"> <paragraph>↓ Lamotrigine </paragraph>
</td>
<td stylecode="     Rrule     " valign="top"> Addition of carbamazepine decreases Lamotrigine concentration approximately 40%. </td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> ? CBZ epoxide</td>
<td stylecode="     Botrule          Rrule     " valign="top"> May increase CBZ epoxide levels. </td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> Phenobarbital/Primidone </td>
<td stylecode="     Botrule          Rrule     " valign="top"> ↓ Lamotrigine </td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decreased Lamotrigine concentration approximately 40%. </td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> Phenytoin (PHT) </td>
<td stylecode="     Botrule          Rrule     " valign="top"> ↓ Lamotrigine </td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decreased Lamotrigine concentration approximately 40%. </td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> Rifampin </td>
<td stylecode="     Botrule          Rrule     " valign="top"> ↓ Lamotrigine </td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decreased Lamotrigine AUC approximately 40%. </td>
</tr>
<tr>
<td rowspan="2" stylecode="     Botrule         Lrule          Rrule     " valign="top"> Valproate </td>
<td stylecode="     Botrule          Rrule     " valign="top"> <paragraph>↑ Lamotrigine </paragraph>
</td>
<td stylecode="     Botrule          Rrule     " valign="top"> Increased Lamotrigine concentrations slightly more than 2-fold. </td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> ? valproate </td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients. </td>
</tr>
</tbody>
</table>